December 2008 Corrections Page
An article originally published Dec. 10, Elan's Martin Named Worst Biotech CEO of '08, incorrectly stated that Louis Bucalo is the chief executive of Titan Pharmaceuticals (TTP:Amex). In fact, Marc Rubin has been Titan's president and CEO since October 2007. Prior to that time, Bucalo held the titles of CEO, president and chairman. Bucalo continued to serve as chairman until April 2008, when he left the board of directors. TheStreet.com regrets the error. (Corrected Dec. 11.)
- Loading Comments...
- Loading Comments...
Recent Comments
Featured Photo Galleries
Connect with TheStreet
 |
 |
-
Fair Game: Loan Pools That Need Some Sun
New York Times
-
U.S. Stocks Climb a Third Week as Fed Repeats Low-Rate Pledge
BusinessWeek Online
-
Boy Charged in Wal-Mart Bias Case in New Jersey
New York Times
-
PIIGS Debt Coming Due
Calculated Risk
-
Bank Failure Update
Calculated Risk
-
UN’s Ban Says Israeli Settlement Building Must End (Update4)
BusinessWeek Online
-
When drug makers' profits outweigh penalties
Washington Post
-
Solution to a thirsty world: sea water without the salt
Latest Business News from Times Online
-
Liberty Global CEO Says It Has Capital To Make Bid For Foxtel
FOXBusiness.com
-
The Threat to Muddle Through
The Big Picture
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note | |
|---|---|---|---|---|
| 10,741.98 | 1,159.90 | 2,374.41 | 36.87 |
Oil *
79.80
|
|
DOWN
37.19
|
DOWN
5.92
|
DOWN
16.87
|
UP
0.15
|
10 Yr
3.69%
SPDR Gold
108.28
|
|
-0.34%
|
-0.51%
|
-0.71%
|
+0.41%
|
Data delayed 20 minutes |
More From TheStreet
Latest Headlines
Brokerage Partners
Sponsored Links
